Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,186
+$3,007 QoQ
Shares Held
65
+38.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,538
of 1,603 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rakuten Securities, Inc. holds $3,655,819 across 14 Drug Manufacturers - General names. NVS ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,505 | $1,805,142 | |
| 2 | PFE |
Pfizer Inc
|
37,692 | $907,623 | |
| 3 | JNJ |
Johnson & Johnson
|
2,241 | $569,146 | |
| 4 | NVO |
Novo Nordisk A S
|
5,064 | $242,768 | |
| 5 | ABBV |
AbbVie Inc.
|
233 | $58,632 | |
| 6 | MRK |
Merck & Co., Inc.
|
214 | $27,499 | |
| 7 | AMGN |
Amgen Inc
|
40 | $14,484 | |
| 8 | NVS |
Novartis AG
This page
|
65 | $10,186 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,186 | 65 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,179 | 47 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $37,087 | 269 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $126,957 | 990 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $726 | 6 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,783 | 16 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $1,459 | 15 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $575 | 5 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $9,581 | 90 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $9,769 | 101 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,817 | 18 | Shares | Defined | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||